Tranexamic OrPha 500 mg, Filmtabletten - 30 Swissmedic Key 70009001 Registration Holder OrPha Swiss GmbH Name Tranexamic OrPha 500 mg, Filmtabletten Date of registration 17.06.2025 Introduction of Sequence 17.06.2025 ATC-Classification Tranexamic Acid (B02AA02) Revision date WHO WHO-DDD Valid until 16.06.2030 Index Therapeuticus (BSV) Show package size 30 Index Therapeuticus (Swissmedic) 06.06. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680700090018 Medication Code Synthetika Pharmacode Disponibility
Composition acidum tranexamicum 500 mg, cellulosum microcristallinum, amylum pregelificatum, povidonum K 30, carmellosum natricum conexum corresp. natrium max. 3.6 mg, talcum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 8000, pro compresso. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Tranexamic Acid 500 mg
Inactive agents Dose additional_information Amylum Pregelificatum Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. Hypromellosum Überzug Macrogol 8000 Magnesii Stearas Povidonum K 30 Pro Compresso Silica Colloidalis Anhydrica Talcum
Source Data was imported : 11.07.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
